Dupixent late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
iSolveSM information on demand is the result of our focus on customer relationship
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
The deal includes upfront payments, milestone payments and ongoing royalties
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Leading USA based genetic testing brand officially enters the Indian market
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Subscribe To Our Newsletter & Stay Updated